Explore 3 Stock Ideas & Industry Insights Download Free Report

News

BNP Paribas Upgrades Barclays PLC (NYSE: BCS) While Wall Street Zen Lowers Rating

Barclays PLC (NYSE: BCS), a multinational financial services provider operating across the UK, Europe, the Americas, Africa, the Middle East, and Asia, has seen a range of recent analyst rating changes. The company operates through two main segments—Barclays UK and Barclays International—offering services from …

Team Kalkine | 22 June 2025

Weekly Market Recap: Geopolitical Tensions, Fed Signals, and Mixed Market Performance

Index Update:President Trump indicated that a decision on striking Iran could take up to two weeks, leaving room for possible negotiations, though tensions remained high with continued Israeli strikes on Iranian nuclear sites. This uncertainty kept investors cautious toward riskier equities, while energy producers …

Team Kalkine | 20 June 2025

Raymond James Maintains "Outperform" Rating on DHT Holdings (NYSE: DHT) Amid Fleet Expansion

DHT Holdings Inc. (NYSE: DHT) continues to draw attention from analysts following its recent move to enhance its shipping fleet. Raymond James and other brokerages have reaffirmed an "Outperform" rating on the oil tanker company, aligning with an average analyst recommendation score of 1.6. …

Team Kalkine | 20 June 2025

OSI Systems (NASDAQ: OSIS) Wins USD 11M European Border Security Contract for Detection Solutions

OSI Systems, Inc. (NASDAQ: OSIS)is a multinational technology company focused on electronic systems and components for homeland security, aerospace, defense, and healthcare industries. The company operates through three business divisions Security, Healthcare, Optoelectronics and Manufacturing.

Team Kalkine | 19 June 2025

Vislink Technologies (OTCQB: VISL) Launches eSIM Integration Across Bonded Cellular Devices

Vislink Technologies, Inc. (OTCQB: VISL)is a U.S.-based global technology provider specializing in live video transmission and wireless communication systems. The company serves clients across broadcasting, defense, and public safety sectors. Vislink’s solutions include video transmission technologies using bonded cellular, IP, radio frequency (RF), and …

Team Kalkine | 19 June 2025

Juniper Networks (NASDAQ: JNPR) Wins Multiple Awards at Interop Tokyo 2025 for AI-Native Networking Solutions

Juniper Networks, Inc. (NASDAQ: JNPR), a provider of secure AI-native networking infrastructure, announced that it has received four awards at Interop Tokyo 2025, one of Asia’s largest and most recognized IT trade events. The company secured two “Best of Show” runner-up awards and two …

Team Kalkine | 19 June 2025

WTW (NASDAQ: WTW) Launches Zest Insurance Platform for Australian SME Sector

WTW (NASDAQ: WTW), is a global advisory, broking, and solutions firm that operates across the areas of people, risk, and capital. The company serves clients in over 140 countries and markets, providing data-driven strategies to help organizations improve decision-making and manage risk. WTW combines …

Team Kalkine | 19 June 2025

QXO (NYSE: QXO) Proposes USD 5Bn Cash Deal to Acquire GMS Shares at Premium

QXO, Inc. (NYSE: QXO)is a U.S.-based distributor of roofing, waterproofing, and related building products. The company has publicly stated its goal to build a scaled technology-enabled distribution platform in the estimated $800 billion building products market. QXO is pursuing growth through both strategic acquisitions …

Team Kalkine | 19 June 2025

Roth Capital Reiterates "Buy" Rating on Verona Pharma (NASDAQ: VRNA)

Roth Capital has reaffirmed its "Buy" rating on shares ofVerona Pharma PLC American Depositary Share(NASDAQ: VRNA) while raising its price target to USD116 from the previously assigned USD92. The revised target was noted in a research report issued Wednesday morning, as reported by Benzinga.

Team Kalkine | 19 June 2025

AbbVie (NYSE: ABBV) Reports Positive Phase 3 Results for Atogepant in Migraine Prevention Study

AbbVie, Inc. (NYSE: ABBV)is a U.S.-based biopharmaceutical company headquartered in North Chicago, Illinois. The firm was spun off from Abbott Laboratories in 2013 and focuses on research and development across several therapeutic areas, including immunology, oncology, neuroscience, and eye care. AbbVie markets several major …

Team Kalkine | 19 June 2025